Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Regarding media reports on a KRW 200B Redeemable Convertible Preferred Stock (RCPS) issuance, Alteogen clarified in this follow-up disclosure that while discussions are ongoing, nothing has been decided and no lead manager contract has been executed.
📊 [Key Disclosure Details & Financial Highlights]
- Target News Report: “Alteogen, No. 1 KOSDAQ Market Cap, to Issue 200B KRW RCPS… Lead Manager Shinhan Securities”
- Media & Report Date: Seoul Finance / 2024-11-21
- Specific Clarification Details:
- Regarding the KRW 200B RCPS issuance, the matter is under consideration, but no concrete decisions have been made to date.
- Contrary to media reports, no lead manager contract has been executed with Shinhan Securities.
- Re-disclosure will be made when specific details are determined or within 1 month.
- Scheduled Re-disclosure Date: 2025-01-20
- Disclosure Officer: Vice President Hang Yeon Kim
- Prior Disclosure History: Clarification on Rumors or News Reports (Unconfirmed) dated 2024-11-21
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Tracking Re-disclosure on RCPS Issuance and Lead Manager Execution
This disclosure updates the re-disclosure schedule regarding the unconfirmed media report concerning the potential KRW 200B capital raise. Verifying whether concrete terms regarding the RCPS issuance and lead manager execution are finalized by the re-disclosure deadline of January 20, 2025, is important to track changes in the company’s financing plans. Further finalized or updated details can be reviewed in subsequent ‘Clarification on Rumors or News Reports’ filings to be submitted around the scheduled re-disclosure date.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
